Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers

1 Jan 2023

Abstract excerpt

Background PTPN2, a member of the non-receptor protein tyrosine phosphatases family, holds a crucial role in tumorigenesis and cancer immunotherapy. However, most studies on the role of PTPN2 in cancer are limited to specific cancer types. Therefore, this study aimed to investigate the prognostic significance of PTPN2 in human cancers and its function in the tumor microenvironment. Methods To shed light on this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes and associated disorders
Share to Otitis Media and Relapsing Polychondritis
Share to Protein Tyrosine Phosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36685446
DOI: 10.1016/j.heliyon.2023.e12873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersPMID 36685446Read ↗

An integrative prognostic and immune analysis of PTPRD in cancerSemantic proximity Read ↗

Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.Semantic proximity Read ↗

PTPRC as a pan-cancer biomarker: Prognostic significance and immune microenvironment interactionsSemantic proximity Read ↗

An Integrative Prognostic and Immune Analysis of PTPRD in Pan-CancerSemantic proximity Read ↗

PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types.Semantic proximity Read ↗

Pan-cancer analysis revealing that PTPN2 is a indicator of risk stratification for acute myeloid leukemia identification of high-risk patientsSemantic proximity Read ↗

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionSemantic proximity Read ↗

PTPN2 Expression in Cystadenocarcinoma Ovary and It’s Clinical Value Based on TCGA DatabaseSemantic proximity Read ↗

Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.Semantic proximity Read ↗

Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes DysfunctionSemantic proximity Read ↗

PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumoursSemantic proximity Read ↗

Overexpression and Prognostic Significance of PTPN2 Maybe A Novel Immunotherapy Target in Renal Clear Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.